重组抗荧光素单抗(4-4-20 (enhanced)),人IgG1-LALAPG Kappa | Syd Labs PA007702.h1LA

重组抗荧光素单抗(4-4-20 (enhanced)),人IgG1-LALAPG Kappa Syd Labs PA007702.h1LA

重组抗荧光素单抗(4-4-20 (enhanced)),人IgG1-LALAPG Kappa | Syd Labs PA007702.h1LA

In stock

一键复制

Syd Labs体内实验级重组抗荧光素(Anti-Fluorescein / Anti-FITC)单克隆抗体,克隆号 4-4-20(enhanced,亲和力增强版),恒定区为‌人 IgG1-LALAPG 效应沉默(effector-silent)Fc 段‌——即在人 IgG1 重链 CH2 结构域引入三个定点突变:‌L234A(亮氨酸→丙氨酸)、L235A(亮氨酸→丙氨酸)、P329G(脯氨酸→甘氨酸,按 EU 编号体系)‌,与 Kappa 轻链配对,由哺乳动物细胞重组表达。该抗体特异性识别荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及 FITC-蛋白/核酸/葡聚糖偶联物具有亚纳摩尔级高亲和力(K_d ~ 10⁻¹⁰ M),保留完整 Fab 抗原结合能力的同时‌彻底消除 Fc 段的全部效应功能‌:L234A/L235A(LALA)双突变破坏 CH2 与 FcγRI/IIa/IIIa 的结合位点,消除 ADCC(抗体依赖性细胞介导的细胞毒性,NK 细胞执行)与 ADCP(抗体依赖性细胞吞噬,巨噬细胞执行);P329G 突变破坏 C1q 结合位点,消除 CDC(补体依赖性细胞毒性);三个突变协同使抗体 Fc 段成为”惰性”骨架,既不杀伤靶细胞、不激活补体、不诱发 FcγR 介导的细胞因子释放,也保留人 FcRn 结合能力维持正常体内半衰期。荧光素(Fluorescein)又称 ‌FITC(异硫氰酸荧光素)、FAM(6-羧基荧光素)、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350‌,是呫吨类绿色荧光染料(Ex≈494 nm/Em≈521 nm),在抗体/蛋白/核酸标记、流式、免疫荧光、侧向流试纸(LFT)中广泛使用。LALAPG 沉默 Fc 版本特别适用于:①体内动物实验(尤其是人源化小鼠/NHP)中的抗 FITC 捕获/清除实验,避免 Fc 介导的意外细胞毒作用;②T 细胞靶向/桥接/共刺激实验中避免抗 CD3 类抗体通过 FcγR 交联引发细胞因子风暴;③作为无效应”空白”阻断/封闭抗体对照;④抗体药物 PK/ADA 生物分析(匹配 LALAPG 工程化候选药 Fc 骨架);⑤IVD/LFT 诊断试剂中消除 Fc-FcγR 非特异结合背景。本品经 Protein A 亲和纯化,还原性 SDS-PAGE 及 HPLC 检测纯度>95%,0.2 μM 过滤于 1× PBS 溶液,适用于 Western Blot、流式细胞术、ELISA、侧向流免疫层析、中和/阻断实验、体内动物实验及 PK/ADA 生物分析。

SKU: PA007702.h1LA 分类: ,

产品参数

货号 PA007702.h1LA
产品名称重组抗荧光素单抗(4-4-20 (enhanced)),人IgG1-LALAPG Kappa | Syd Labs PA007702.h1LA
英文名 Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Human IgG1-L234A L235A P329G (LALAPG) Kappa
供货商名称 Syd Labs, Inc.
品牌名 Syd Labs
别称 Fluorescein、FITC(Fluorescein isothiocyanate / 异硫氰酸荧光素 / 荧光素异硫氰酸酯)、FAM(6-Carboxyfluorescein / 6-羧基荧光素)、Fluorescein isomer I、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350、D&C Yellow No.7
克隆号 4-4-20 (enhanced)
同种型 人 IgG1-LALAPG Kappa
特异性 特异性结合荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及 FITC-蛋白/抗体/葡聚糖/核酸偶联物均有高亲和力
抗体形式 0.2 μM 过滤的 1× PBS 溶液
纯度 还原性条件下 SDS-PAGE 及 HPLC 检测>95%
运输 采用冰袋运输;收到后请立即按下方推荐温度保存
稳定性与存储 使用手动除霜冰箱,避免反复冻融;自收货之日起 12 个月,按供货状态于 −20 ℃ 至 −70 ℃ 保存;自收货之日起 1 个月,按供货状态于 2 ℃ 至 8 ℃ 保存
产品咨询 Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。
关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理)
应用详情 Western Blot(蛋白质印迹)、Flow Cytometry(流式细胞术);可用于 ELISA、侧向流免疫层析试纸(LFT/LFD)、中和/阻断实验、体内动物实验(人源化小鼠/NHP)、T 细胞桥接/共刺激功能实验、效应沉默抗体药物 PK/ADA 生物分析及 IVD 诊断试剂开发

文献

PA007702.h1LA: Syd Labs 重组抗荧光素单克隆抗体(克隆号4-4-20 (enhanced)) ,人IgG1-LALAPG Kappa(Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Human IgG1-L234A L235A P329G (LALAPG) Kappa)

重组抗荧光素单抗(4-4-20 (enhanced))背景知识:

我们的重组抗荧光素抗体(克隆号 4-4-20 增强型)为序列明确、哺乳动物细胞表达的抗 FITC 单克隆抗体,可特异性识别结合在蛋白、多肽、核酸或固相基质上的荧光素母核结构。该重组抗荧光素半抗原抗体稳定性高、性能可靠,是识别荧光素标记靶标、在各类常规体外免疫检测中放大信号的关键二步检测试剂,可彻底规避杂交瘤细胞株遗传漂移带来的风险。

相较于传统生物素 – 链霉亲和素体系,荧光素 / 抗荧光素检测体系具备突出优势:生物素广泛存在于多种哺乳动物组织及细胞裂解液中,因此基于生物素的检测往往背景偏高、易出现假阳性;而生物样本中天然不含荧光素,使用这款重组抗 FITC 单克隆抗体能够完全消除内源背景干扰。因此,该抗荧光素半抗原抗体非常适合用于复杂样本的体外诊断、ELISA 以及高通量筛选平台,可获得低背景、高准确度的实验数据。

我们可针对 4-4-20 增强型骨架提供全套抗体定制改造与规模化生产服务,面向诊断试剂盒研发企业及科研实验室。可提供的定制类型包括:
亚型转换与 Fc 改造:多种重链 / 轻链亚型以及改造型 Fc 变体(如效应沉默 LALAPG 突变体);
亲和标签:可重组添加 Avi 标签、His 标签或 DYKDDDDK(FLAG)标签,适配特定实验取向;
标记偶联:生物素化版本,也可直接偶联多种荧光基团、染料以及酶(辣根过氧化物酶 HRP、碱性磷酸酶 AP)。

重组抗荧光素单抗(4-4-20 (enhanced))部分参考文献:

1. CRISPR/Cas12a and fork-shaped probe enhance LAMP-LFT integration for equipment-free detection of Listeria monocytogenes.
Safenkova IV, et al.
Food Res Int. 2026 Apr;230:118592. PMID: 41794473 DOI: 10.1016/j.foodres.2026.118592
“An isothermal amplification assay integrated with lateral flow test (LFT) was developed for equipment-free detection of Listeria monocytogenes. In both LAMP-LFT and LAMP-CRISPR/Cas12a-LFT formats, fluorescein- and biotin-labeled amplicons were detected using a common conjugate of gold nanoparticles and anti-fluorescein (anti-FAM) antibodies, with a cleaved fork-shaped multi-fluorescein probe enabling visual readout on strips coated with anti-FAM capture antibody. The optimized assay achieved a single-cell detection limit (0.2 cells/reaction in buffer, 1 cell/reaction in spiked milk) within 80 min.”

2.A Versatile Cytochemical Labeling Technique as a Forensic Decision-Support Tool for In Situ Detection of Cell-Derived Markers in Invisible Biological Traces.
Bastat M, et al.
Anal Chem. 2025 Oct;97(41):22497–22507. PMID: 41057037 DOI: 10.1021/acs.analchem.5c02284
“A dual chromogenic and fluorescent in situ cytochemistry tool was developed to highlight invisible touch-DNA traces (e.g., fingermark corneocytes) on crime-scene surfaces. Chromogenic labeling of mannose residues and keratin 10 allowed visualization of as few as 100 shed cells, while a combination of FITC-conjugated primary probes and an HRP-conjugated anti-FITC antibody enabled simultaneous chromogenic and fluorescent detection across light and opaque substrates (ceramic, metal), supporting on-field sampling decisions prior to DNA extraction.”

3.Development of Reverse Transcriptase Recombinase Polymerase Amplification Combined with Lateral Flow Dipstick for Rapid Detection of Tilapia Lake Virus (TiLV): Pilot Study.
Srivorakul S, et al.
Vet Sci. 2025 Sep;12(9):845. PMID: 41012770 DOI: 10.3390/vetsci12090845
“A reverse-transcriptase recombinase polymerase amplification assay combined with a lateral flow dipstick (RT-RPA-LFD) was developed for point-of-care detection of Tilapia Lake Virus. The dipstick was prepared with immobilized anti-FITC and anti-biotin capture antibodies compatible with TiLV-specific primers tagged with FITC and biotin. Reverse transcription and RPA amplification were completed at 39 °C within 20 min, and products were visualized as a positive band on the LFD, achieving a 3.19 copies/µL limit of detection—a 100-fold improvement over RT-PCR-LFD.”

4.Identification, sorting and profiling of functional killer cells via the capture of fluorescent target-cell lysate.
Luah YH, et al.
Nat Biomed Eng. 2024 Mar;8(3):248–262. PMID: 37652987 DOI: 10.1038/s41551-023-01089-z
“PAINTKiller, a flow-cytometry-compatible assay for identifying and sorting functional cytotoxic effector cells in co-cultures, relies on capturing the intracellular carboxyfluorescein succinimidyl ester released from lysed target cells onto the surface of the killing lymphocyte. Capture was achieved using a bispecific complex consisting of an anti-fluorescein isothiocyanate antibody linked to an antibody against the pan-leucocyte receptor CD45, which ‘painted’ the natural killer cell surface with fluorescent lysate and enabled FACS sorting followed by single-cell RNA-seq profiling of killer-cell subpopulations.”

5.Fluorescein-switching-based lateral flow assay for the detection of microRNAs.
Ryu JY, et al.
Org Biomol Chem. 2024 Oct;22(40):8182–8188. PMID: 39291769 DOI: 10.1039/d4ob01311e
“A fluorescein-switching lateral flow assay was developed for naked-eye detection of microRNA biomarkers (miR-6090 and miR-141 for prostate cancer). Reduced fluorescein on the probe only weakly binds gold-nanoparticle-conjugated anti-fluorescein antibodies; in the presence of target microRNA, riboflavin tetraacetate photo-oxidizes the probe back to native fluorescein, which strongly binds the antibodies on the strip to produce a visible line. Sodium borohydride was introduced to minimize background, enabling fmol-level microRNA detection with minimal false positives for point-of-care cancer diagnostics.”